An Update on JAK Inhibitors in Skin Disease

Cutis. 2022 Mar;109(3):122-124. doi: 10.12788/cutis.0477.

Authors

Alexandra Norden¹, Aislyn Oulee¹, Sogol Stephanie Javadi¹, Jashin J Wu¹

Affiliation

¹ Ms. Norden is from the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York. Ms. Oulee is from the School of Medicine, University of California Riverside. Ms. Javadi is from the David Geffen School of Medicine, University of California, Los Angeles. Dr. Wu is from the Dermatology Research and Education Foundation, Irvine, California.

PMID: 35659132
DOI: 10.12788/cutis.0477

No abstract available

Publication types

Editorial

MeSH terms

Dermatitis, Atopic*
Humans
Janus Kinase Inhibitors* / pharmacology
Janus Kinase Inhibitors* / therapeutic use
Janus Kinases
Skin Diseases* / drug therapy

Substances

Janus Kinase Inhibitors
Janus Kinases